With an eye-catching exhibit, powerful technology demos, a high-profile speaking opportunity, and memorable marketing outside the convention center, Health Decisions made a big impact at DIA... Read more
Recently, Health Decisions CEO Michael Rosenberg had an opportunity to sit down with Dr. Adam Goldstein and Dr. Adam Zolotor on Here's to Your Health, UNC Family Medicine's radio talk... Read more
Health Decisions recently signed an agreement to utilize OmniComm's TrialMaster eClinical products platform to drive operational efficiences and provide a wider range of EDC options to sponsors.... Read more
This month the FDA released a new draft guidance on adaptive designs in clinical trials. The document provides advice on best practices for planning and conducting these studies, and outlines... Read more
We’d like to extend our congratulations to Dr. Michael Rosenberg, our CEO and resident author, on the release of his new book: The Agile Approach to Adaptive Research: Optimizing... Read more
In a recent Wall Street Journal column , Thomas Friedman presents an interesting take on the Chinese economy, which brings to mind an interesting parallel with the drug development industry. He... Read more
After a year of legislation and congressional speculation insulating medical device makers from lawsuits and economic penalties, it looks as though the FDA will replace its favor with the same... Read more
A recent article (originally appearing in Oncology NEWS International Vol. 18 No. 12) discusses traditional Phase II trials for oncology and whether or not they should be phased out. The author... Read more
We recently got a chance to chat with Applied Clinical Trials’ Lisa Henderson about our new network approach to global clinical development. Coming face to face with breaking industry... Read more
At the Fourth Annual Site Solutions Summit in October , 150 site stakeholders and two dozen sponsors and CROs achieved consensus on six site best practices. Organizers of the event said if... Read more
